Vicarious Surgical Stock In Shambles: Down -48% With 9-Day Losing Streak
Vicarious Surgical (RBOT) stock hit day 9 of a continuous streak of days with losses, with cumulative losses over this period amounting to a -48% return. The company has lost about $13 Mil in value over the last 9 days, with its current market capitalization at about $15 Mil. The stock remains 81.3% below its value at the end of 2024. This compares with year-to-date returns of 12.3% for the S&P 500.
Vicarious Surgical’s recent streak reflects ongoing investor apprehension regarding its extended surgical robot development timeline and substantial cash burn, despite Q3’25 efforts to narrow losses. Skepticism over its commercialization path overshadowed cost controls, fueling a sharp decline as market sentiment soured on its long-term viability.
What is the point? Sustained weakness can be more than noise. It often signals shifting sentiment or deeper concerns. A multi-day losing streak may warn of further downside, or present an opportunity to buy if fundamentals are intact.For quick background, RBOT provides single-incision surgical robots that virtually immerse surgeons inside patients for minimally invasive procedures, enhancing precision and reducing recovery time.
Comparing RBOT Stock Returns With The S&P 500
- Palantir At 80x Earnings: What Revenue Growth Rate Justifies The Valuation?
- Should You Pay Attention To Chevron Stock’s Momentum?
- What Is Happening With Caterpillar Stock?
- What Can Trigger Microsoft Stock’s Slide?
- Is Microsoft Stock A Trap Or A Missed Opportunity?
- Earn 9.6% Today or Buy BSX 30% Cheaper – It’s a Win-Win
The following table summarizes the return for RBOT stock vs. the S&P 500 index over different periods, including the current streak:
| Return Period | RBOT | S&P 500 |
|---|---|---|
| 1D | -4.7% | 1.0% |
| 9D (Current Streak) | -47.9% | -3.4% |
| 1M (21D) | -58.9% | -2.0% |
| 3M (63D) | -63.3% | 2.5% |
| YTD 2025 | -81.3% | 12.3% |
| 2024 | 19.6% | 23.3% |
| 2023 | -81.8% | 24.2% |
| 2022 | -81.0% | -19.4% |
Gains and Losses Streaks: S&P 500 Constituents
There are currently 46 S&P constituents with 3 days or more of consecutive gains and 20 constituents with 3 days or more of consecutive losses.
| Consecutive Days | # of Gainers | # of Losers |
|---|---|---|
| 3D | 23 | 10 |
| 4D | 19 | 3 |
| 5D | 1 | 5 |
| 6D | 0 | 0 |
| 7D or more | 3 | 2 |
| Total >=3 D | 46 | 20 |
Key Financials for Vicarious Surgical (RBOT)
Last 2 Fiscal Years:
| Metric | FY2023 | FY2024 |
|---|---|---|
| Revenues | $0 | $0 |
| Operating Income | $-80.7 Mil | $-66.6 Mil |
| Net Income | $-71.1 Mil | $-63.2 Mil |
Last 2 Fiscal Quarters:
| Metric | 2025 FQ1 | 2025 FQ2 |
|---|---|---|
| Revenues | $0 | $0 |
| Operating Income | $-15.7 Mil | $-13.5 Mil |
| Net Income | $-15.4 Mil | $-13.2 Mil |
The losing streak RBOT stock is currently on doesn’t inspire much confidence among investors. In contrast, Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 — the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.